Urodynamic findings and vibegron effects on neurogenic lower urinary tract dysfunction caused by human T‐cell leukemia virus type I‐associated myelopathy/tropical spastic paraparesis
In patients for whom OAB and DO do not improve with steroid treatment and solifenacin, treatment with vibegron may improve OAB symptoms.
Authors
- Yuki Harigane (ORCID: https://orcid.org/0009-0001-8696-9853)
- Hidenori Akaihata
- Ryo Tanji
- Hiroki Natsuya
- Tomoyuki Kumekawa (ORCID: https://orcid.org/0009-0001-6402-9983)
- Soichiro Ogawa (ORCID: https://orcid.org/0000-0001-6002-7879)
- Hitomi Imai (ORCID: https://orcid.org/0009-0008-6899-2110)
- Kanako Matsuoka (ORCID: https://orcid.org/0000-0002-0731-4577)
- Junya Hata (ORCID: https://orcid.org/0000-0002-7912-5468)
- Yoshiyuki Kojima (ORCID: https://orcid.org/0000-0002-8085-0341)
Institutions
- Fukushima Medical University (JP)
Publication Details
- Journal
- IJU Case Reports
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1002/iju5.12773
- Citations
- 1
- Primary Topic
- T-cell and Retrovirus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.24